Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Avogaro

Showing results (161-170 of 426) with videos related to

Pageof 43
Sort By:
Plos One|April 18, 2012
Glucose and fatty acid metabolism in a 3 tissue in-vitro model challenged with normo- and hyperglycaemiaElisabetta Iori, Bruna Vinci, Ellen Murphy, et al.
Diabetes & Vascular Disease Research|May 3, 2019
Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndromeAngelo Avogaro, Enzo Bonora, Agostino Consoli, et al.
Biotechnology Journal|June 3, 2010
Flow-regulated glucose and lipid metabolism in adipose tissue, endothelial cell and hepatocyte cultures in a modular bioreactorBruna Vinci, Ellen Murphy, Elisabetta Iori, et al.
Acta Diabetologica|September 16, 2024
The socio-environmental determinants of diabetes and their consequencesAngelo Avogaro, Mauro Rigato, Eugenio di Brino, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 10, 2021
Beneficial effects of glucagon-like peptide 1 receptor agonists on glucose control, cardiovascular risk profile, and non-alcoholic fatty liver disease. An expert opinion of the Italian diabetes societyRaffaele Napoli, Angelo Avogaro, Gloria Formoso, et al.
Cardiovascular Diabetology|February 11, 2017
DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetesGian Paolo Fadini, Benedetta Maria Bonora, Mattia Albiero, et al.
Clinical Drug Investigation|April 14, 2010
Two cases of statin-induced rhabdomyolysis associated with mononeuropathyGian Paolo Fadini, Enzo Manzato, Cristina Crepaldi, et al.
Diabetes|February 28, 2003
L-arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approachAngelo Avogaro, Gianna Toffolo, Edward Kiwanuka, et al.
Diabetes Technology & Therapeutics|September 3, 2010
Continuous glucose monitoring reveals delayed nocturnal hypoglycemia after intermittent high-intensity exercise in nontrained patients with type 1 diabetesAlberto Maran, Paola Pavan, Barbara Bonsembiante, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 24, 2019
Diabetes diagnosis from administrative claims and estimation of the true prevalence of diabetes among 4.2 million individuals of the Veneto region (North East Italy)Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, et al.
Pageof 43

Showing results (161-170 of 426) with videos related to

Sort By:
Pageof 43
Plos One|April 18, 2012
Glucose and fatty acid metabolism in a 3 tissue in-vitro model challenged with normo- and hyperglycaemiaElisabetta Iori, Bruna Vinci, Ellen Murphy, et al.
Diabetes & Vascular Disease Research|May 3, 2019
Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndromeAngelo Avogaro, Enzo Bonora, Agostino Consoli, et al.
Biotechnology Journal|June 3, 2010
Flow-regulated glucose and lipid metabolism in adipose tissue, endothelial cell and hepatocyte cultures in a modular bioreactorBruna Vinci, Ellen Murphy, Elisabetta Iori, et al.
Acta Diabetologica|September 16, 2024
The socio-environmental determinants of diabetes and their consequencesAngelo Avogaro, Mauro Rigato, Eugenio di Brino, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 10, 2021
Beneficial effects of glucagon-like peptide 1 receptor agonists on glucose control, cardiovascular risk profile, and non-alcoholic fatty liver disease. An expert opinion of the Italian diabetes societyRaffaele Napoli, Angelo Avogaro, Gloria Formoso, et al.
Cardiovascular Diabetology|February 11, 2017
DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetesGian Paolo Fadini, Benedetta Maria Bonora, Mattia Albiero, et al.
Clinical Drug Investigation|April 14, 2010
Two cases of statin-induced rhabdomyolysis associated with mononeuropathyGian Paolo Fadini, Enzo Manzato, Cristina Crepaldi, et al.
Diabetes|February 28, 2003
L-arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approachAngelo Avogaro, Gianna Toffolo, Edward Kiwanuka, et al.
Diabetes Technology & Therapeutics|September 3, 2010
Continuous glucose monitoring reveals delayed nocturnal hypoglycemia after intermittent high-intensity exercise in nontrained patients with type 1 diabetesAlberto Maran, Paola Pavan, Barbara Bonsembiante, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 24, 2019
Diabetes diagnosis from administrative claims and estimation of the true prevalence of diabetes among 4.2 million individuals of the Veneto region (North East Italy)Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, et al.
Pageof 43